RDY Other Assets from 2010 to 2024

RDY Stock  USD 68.68  1.18  1.69%   
Dr Reddys Other Assets yearly trend continues to be fairly stable with very little volatility. Other Assets are likely to outpace its year average in 2024. During the period from 2010 to 2024, Dr Reddys Other Assets regression line of annual values had r-squared of  0.62 and arithmetic mean of  5,810,381,734. View All Fundamentals
 
Other Assets  
First Reported
2000-03-31
Previous Quarter
112 B
Current Value
11.3 B
Quarterly Volatility
20.3 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RDY main balance sheet or income statement drivers, such as Interest Expense of 1.7 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many exotic indicators such as Price To Sales Ratio of 3.51, Dividend Yield of 0.0054 or PTB Ratio of 4.19. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
This module can also supplement Dr Reddys' financial leverage analysis and stock options assessment as well as various Dr Reddys Technical models . Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Other Assets Growth Pattern

Below is the plot of the Other Assets of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Slightly volatile
   Other Assets   
       Timeline  

RDY Other Assets Regression Statistics

Arithmetic Mean5,810,381,734
Geometric Mean518,806,809
Coefficient Of Variation87.29
Mean Deviation4,049,436,817
Median6,060,000,000
Standard Deviation5,072,088,377
Sample Variance25726080.5T
Range14.8B
R-Value0.79
Mean Square Error10620831.4T
R-Squared0.62
Significance0.0005
Slope890,614,393
Total Sum of Squares360165127.1T

RDY Other Assets History

20248.6 B
20238.2 B
20227.1 B
202113.7 B
202011.6 B
201914.8 B
20185.2 B

About Dr Reddys Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dr Reddys income statement, its balance sheet, and the statement of cash flows. Dr Reddys investors use historical funamental indicators, such as Dr Reddys's Other Assets, to determine how well the company is positioned to perform in the future. Although Dr Reddys investors may use each financial statement separately, they are all related. The changes in Dr Reddys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dr Reddys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dr Reddys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Assets8.2 B8.6 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out the analysis of Dr Reddys Correlation against competitors.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.36
Dividend Share
40
Earnings Share
4.01
Revenue Per Share
280.1794
Quarterly Revenue Growth
0.125
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.